213 related articles for article (PubMed ID: 27518753)
21. An open, randomized trial of three-day treatment with artesunate combined with a standard dose of mefloquine divided over either two or three days, for acute, uncomplicated falciparum malaria.
Silachamroon U; Krudsood S; Thanachartwet W; Tangpukdee N; Leowattana W; Chalermrut K; Srivilairit S; Wilaiaratana P; Thimasarn K; Looareesuwan S
Southeast Asian J Trop Med Public Health; 2005 May; 36(3):591-6. PubMed ID: 16124422
[TBL] [Abstract][Full Text] [Related]
22. UK malaria treatment guidelines.
Lalloo DG; Shingadia D; Pasvol G; Chiodini PL; Whitty CJ; Beeching NJ; Hill DR; Warrell DA; Bannister BA;
J Infect; 2007 Feb; 54(2):111-21. PubMed ID: 17215045
[TBL] [Abstract][Full Text] [Related]
23. Editorial commentary: single-dose primaquine as gametocytocidal treatment in patients with uncomplicated falciparum malaria.
Dondorp AM
Clin Infect Dis; 2013 Mar; 56(5):694-6. PubMed ID: 23175557
[No Abstract] [Full Text] [Related]
24. Artemether-lumefantrine: an oral antimalarial for uncomplicated malaria in children.
Adjei GO; Goka BQ; Binka F; Kurtzhals JA
Expert Rev Anti Infect Ther; 2009 Aug; 7(6):669-81. PubMed ID: 19681693
[TBL] [Abstract][Full Text] [Related]
25. Artesunate: investigational drug for the treatment of severe falciparum malaria in Hawai'i.
Callender DM; Hsue G
Hawaii Med J; 2011 Apr; 70(4):77-9. PubMed ID: 21785506
[TBL] [Abstract][Full Text] [Related]
26. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
[TBL] [Abstract][Full Text] [Related]
27. [Therapeutic effect of 138 imported falciparum malaria patients].
Yu ZH; Wang FY; Wei DD; Yin B; Wei YB; Zhao GH; Zhang BG; Wang YB
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2014 Dec; 26(6):669-71, 677. PubMed ID: 25856897
[TBL] [Abstract][Full Text] [Related]
28. Artesunate/mefloquine paediatric formulation vs. artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum in Anonkoua kouté, Côte d'Ivoire.
Toure OA; Kouame MG; Didier YJ; Berenger AA; Djerea K; Genevieve GO; Penali LK
Trop Med Int Health; 2011 Mar; 16(3):290-7. PubMed ID: 21214690
[TBL] [Abstract][Full Text] [Related]
29. Artemisinin resistance in Plasmodium falciparum malaria.
Taylor SM; Juliano JJ; Meshnick SR
N Engl J Med; 2009 Oct; 361(18):1807; author reply 1808. PubMed ID: 19864681
[No Abstract] [Full Text] [Related]
30. Comparison of artesunate and quinine in the treatment of Sudanese children with severe Plasmodium falciparum malaria.
Eltahir HG; Omer AA; Mohamed AA; Adam I
Trans R Soc Trop Med Hyg; 2010 Oct; 104(10):684-6. PubMed ID: 20850004
[TBL] [Abstract][Full Text] [Related]
31. Artemisinin resistance in Plasmodium falciparum malaria.
Htut ZW
N Engl J Med; 2009 Oct; 361(18):1807-8; author reply 1808. PubMed ID: 19877309
[No Abstract] [Full Text] [Related]
32. Combined intravenous treatment with artesunate and quinine for severe malaria in Italy.
Bartoloni A; Tomasoni L; Bartalesi F; Galli L; Sani S; Veloci S; Zammarchi L; Pini A; Castelli F
Am J Trop Med Hyg; 2010 Aug; 83(2):274-6. PubMed ID: 20682867
[TBL] [Abstract][Full Text] [Related]
33. A prospective comparative study of knowlesi, falciparum, and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax but no mortality with early referral and artesunate therapy.
Barber BE; William T; Grigg MJ; Menon J; Auburn S; Marfurt J; Anstey NM; Yeo TW
Clin Infect Dis; 2013 Feb; 56(3):383-97. PubMed ID: 23087389
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal.
Faye B; Ndiaye JL; Ndiaye D; Dieng Y; Faye O; Gaye O
Malar J; 2007 Jun; 6():80. PubMed ID: 17570848
[TBL] [Abstract][Full Text] [Related]
35. Rational deployment of antimalarial drugs in Africa: should first-line combination drugs be reserved for paediatric malaria cases?
Sutherland CJ; Babiker H; Mackinnon MJ; Ranford-Cartwright L; El Sayed BB
Parasitology; 2011 Oct; 138(12):1459-68. PubMed ID: 21810298
[TBL] [Abstract][Full Text] [Related]
36. Cryptic severe
Zammarchi L; Di Lauria N; Bartalesi F; Suardi LR; Corti G; Mencarini J; Boccolini D; Severini C; Gradoni L; Buonamici C; Garofalo G; Bartolesi AM; Ciccone N; Berni A; Poggesi L; Niccolini F; Rossolini GM; Romi R; Bartoloni A
Euro Surveill; 2018 Oct; 23(41):. PubMed ID: 30326993
[TBL] [Abstract][Full Text] [Related]
37. Plasmodium falciparum malaria in infants under 5 kg: retrospective surveillance of hospital records in five sub-saharan African countries.
Alao MJ; Gbadoé AD; Meremikwu M; Tshefu A; Tiono AB; Cousin M; Hamed K
J Trop Pediatr; 2013 Apr; 59(2):154-9. PubMed ID: 23243081
[TBL] [Abstract][Full Text] [Related]
38. In Vivo Efficacy and Tolerability of Artesunate-Azithromycin for the Treatment of Falciparum Malaria in Vietnam.
Phong NC; Quang HH; Thanh NX; Trung TN; Dai B; Shanks GD; Chavchich M; Edstein MD
Am J Trop Med Hyg; 2016 Jul; 95(1):164-7. PubMed ID: 27215294
[TBL] [Abstract][Full Text] [Related]
39. Evidence of artemisinin-resistant malaria in western Cambodia.
Noedl H; Se Y; Schaecher K; Smith BL; Socheat D; Fukuda MM;
N Engl J Med; 2008 Dec; 359(24):2619-20. PubMed ID: 19064625
[No Abstract] [Full Text] [Related]
40. Why the world needs another malaria initiative.
Lancet; 2004 Jul 31-Aug 6; 364(9432):389-90. PubMed ID: 15288715
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
